AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-17 Cr | ₹12 Cr | ₹-71 Cr | ₹78 Cr | - |
What is the latest Net Cash Inflow / Outflow ratio of AARTI PHARMALABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-17 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹-71 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | - |
How is Net Cash Inflow / Outflow of AARTI PHARMALABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-17 Cr | Negative | |
| Mar2024 | ₹12 Cr | Positive | |
| Mar2023 | ₹-71 Cr | Negative | |
| Mar2022 | ₹78 Cr | 0 | |
| Mar2021 | - | - | |
Compare Net Cash Inflow / Outflow of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,434.7 Cr | 3.1% | 11.1% | -5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,830.0 Cr | 5.9% | -0.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.5% | 8.7% | 3.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,166.0 Cr | 2% | -1.6% | 25.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | -0.2% | 2.2% | 12.8% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 0.8% | 5.9% | -15.7% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 3.1% |
11.1% |
-5.2% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses